选择语言

Human CD27 Ligand / CD70 Protein, His,Flag Tag, active trimer (MALS verified)

用户评价
货号-规格
价格
Qty.
CDL-H52Da-100ug
¥3675.00
CDL-H52Da-1mg
¥24255.00
合计0件 产品金额¥ 0

产品详情

  • 分子别名(Synonym)

    CD70,CD27LG,TNFSF7,TNFSF7G,CD27L

  • 表达区间及表达系统(Source)

    Human CD27 Ligand Protein, His,Flag Tag (CDL-H52Da) is expressed from human 293 cells (HEK293). It contains AA Ser 52 - Pro 193 (Accession # P32970-1) trimer Design.

    Predicted N-terminus: His

  • 蛋白结构(Molecular Characterization)

    This protein carries a polyhistidine tag at the N-terminus, followed by a flag tag.

    The protein has a calculated MW of 49.3 kDa. The protein migrates as 50-60 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under non-reducing (NR) condition (SDS-PAGE) due to glycosylation.

  • 偶联(Conjugate)

    Unconjugated

  • 内毒素(Endotoxin)

    Less than 1.0 EU per μg by the LAL method.

  • 纯度(Purity)

    95% as determined by SDS-PAGE.

    90% as determined by SEC-MALS.

  • 制剂(Formulation)

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • 重构方法(Reconstitution)

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • 存储(Storage)

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

产品展示

  • 电泳(SDS-PAGE)

    CD27 Ligand SDS-PAGE

    Human CD27 Ligand Protein, His,Flag Tag on SDS-PAGE under non-reducing (NR) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    CD27 Ligand SEC-MALS

    The purity of Human CD27 Ligand Protein, His,Flag Tag (Cat. No. CDL-H52Da) is more than 90% and the molecular weight of this protein is around 55-70 kDa verified by SEC-MALS.

    Report
  • 活性(Bioactivity)-ELISA

     CD27 Ligand ELISA

    Immobilized Human CD27 Ligand Protein, His,Flag Tag (Cat. No. CDL-H52Da) at 2 μg/mL (100 μL/well) can bind Human CD27, Fc Tag (Cat. No. CD7-H5254) with a linear range of 2-125 ng/mL (QC tested).

    Protocol
  •  CD27 Ligand ELISA

    Serial dilutions of Anti-CD27 Ligand (cusatuzumab) Antibody, Human IgG1 were added into Human CD27 Ligand Protein, His,Flag Tag (Cat. No. CDL-H52Da) : Biotinylated Human CD27, Fc,Avitag (Cat. No. TN7-H82F6) binding reactions. The half maximal inhibitory concentration (IC50) is 0.42856 μg/mL (Routinely tested).

    Protocol
  •  CD27 Ligand ELISA

    Immobilized Human CD27, Fc Tag (Cat. No. CD7-H5254) at 5 μg/mL (100 μL/well) can bind Human CD27 Ligand Protein, His,Flag Tag (Cat. No. CDL-H52Da) with a linear range of 0.6-20 ng/mL (Routinely tested).

    Protocol

用户评价
发表评论

背景介绍

Cluster of Differentiation 70 (CD70) is also known as CD27 ligand (CD27L / CD27LG), TNFSF7, TNFSF7G, is a type II transmembrane glycoprotein belonging to the TNF superfamily (TNFSF) and is a surface antigen found on activated T-and B-lymphocytes and mature dendritic cells. Binding of CD70 to its receptor CD27 induces in priming, effector functions, differentiation and memory formation of T-cells, and thus is invloved in the biological processes including T-cell activation, the proliferation of costimulated T-cells, as well as the generation of cytolytic T-cells. CD70 on T cells provides costimulatory signals that are required for T cell proliferation, clonal expansion and the promotion of effector T cell formation. CD70 on mouse B cell has been shown to inhibit terminal differentiation of activated B cells into plasma cells and enhances commitment to memory B cell responses. CD70 induces proliferation and IFNγ production, on NK cells.

前沿进展

 
药物研发进展
  • 英文全称:

    CD70 antigen

  • 中文全称:

    CD70抗原

  • 种类:

  • 上市药物数量:

    0 详情

  • 临床药物数量:

    30 详情

  • 最高研发阶段:

    临床二期

联系我们
项目合作
查看更多项目
  • 产品SKU
  • 产品详情
  • 产品展示
  • 用户评价
  • 背景介绍